Showing results (421-430 of 530) with videos related to
Sort By:
Pageof 53
Cancer|June 14, 2017
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancerMark M Pomerantz, Sandor Spisák, Li Jia, et al.BMC Cancer|August 18, 2011
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort studyS Yousuf Zafar, Jennifer L Malin, Steven C Grambow, et al.Journal of the National Cancer Institute|August 3, 2023
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancerHagen F Kennecke, Rebecca Auer, May Cho, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel AdenocarcinomaAlicia Latham, Jinru Shia, Zalak Patel, et al.Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.JAMA Network Open|July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric CancerGeoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical ProfilesBeryl L Manning-Geist, Ying L Liu, Kelly A Devereaux, et al.Public Health Genomics|April 16, 2009
A health services research agenda for cellular, molecular and genomic technologies in cancer careLouise Wideroff, Kathryn A Phillips, Gurvaneet Randhawa, et al.Investigational New Drugs|January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.Pageof 53